Loading...
Indian Pharmaceutical Exporter · Vitamins & Supplements Specialist · $5.2M Total Trade · DGFT Verified
Gopaldas Visram AND Company Limited is an Indian pharmaceutical exporter with a total trade value of $5.2M across 2 products in 2 therapeutic categories. Based on 344 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Zinc ($3.9M), Hydrocortisone ($1.2M), .
Gopaldas Visram & Company Limited (GVCL) is a prominent Indian pharmaceutical exporter specializing in the development and manufacturing of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established in 1945, the company has over 70 years of experience in the pharmaceutical and cosmeceutical sectors. GVCL operates from its headquarters located at Persian Apartment, Plot No-434, Ground Floor V P Road, Andheri West, Mumbai, Maharashtra 400058. The company is registered under the Corporate Identification Number (CIN) U52100MH2005PLC156917. As of the latest available data, GVCL has an authorized share capital of ₹15.00 crore and a paid-up capital of ₹9.99 crore. The company employs approximately 259 professionals. GVCL's official website is gopaldasvisram.com.
Gopaldas Visram AND Company Limited operates across 2 therapeutic categories, with Vitamins & Supplements (76.3%), Corticosteroids (23.7%), representing the largest segments by export value. The portfolio is concentrated — the top 5 products account for 100% of total exports.
Vitamins & Supplements
1 products · 76.3% · $3.9M
Corticosteroids
1 products · 23.7% · $1.2M
Gopaldas Visram AND Company Limited exports 2 pharmaceutical products across 2 therapeutic categories.
| # | Product | Category | Export Value | Shipments | Market Share | Rank |
|---|---|---|---|---|---|---|
| 1 | Zinc | Vitamins & Supplements | $3.9M | 224 | 5.0% | 3 |
| 2 | Hydrocortisone |
Headquarters, ownership, manufacturing facilities, and key leadership
Gopaldas Visram & Company Limited (GVCL) is a prominent Indian pharmaceutical exporter specializing in the development and manufacturing of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established in 1945, the company has over 70 years of experience in the pharmaceutical and cosmeceutical sectors. GVCL operates from its headquarters located at Persian Apartment, Plot No-434, Ground Floor V P Road, Andheri West, Mumbai, Maharashtra 400058. The company is registered under the Corporate Identification Number (CIN) U52100MH2005PLC156917. As of the latest available data, GVCL has an authorized share capital of ₹15.00 crore and a paid-up capital of ₹9.99 crore. The company employs approximately 259 professionals. GVCL's official website is gopaldasvisram.com.
GVCL boasts a manufacturing area exceeding 220,000 square feet, equipped with state-of-the-art Quality Assurance (QA) and Quality Control (QC) laboratories. The company's manufacturing facilities are WHO-GMP certified, ISO 9001:2015 certified, and US FDA approved, ensuring adherence to international quality standards. GVCL's manufacturing capabilities encompass the production of liquids, ointments, powders, granules, and dusting powders, catering to a diverse range of pharmaceutical and cosmeceutical products.
| $1.2M |
| 120 |
1.9% |
| 11 |
Gopaldas Visram AND Company Limited exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $5.2M. The top category is Vitamins & Supplements (76.3% of portfolio), followed by Corticosteroids (23.7%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.
Shipment-level records, pricing & buyer contacts for Gopaldas Visram AND Company Limited.
Request DemoGVCL's leadership team comprises experienced professionals dedicated to the company's growth and operational excellence. Mr. Dinesh Vallabhdas Thakker serves as the Managing Director, overseeing the comprehensive affairs of the group, including sales and marketing. Mr. Mukund Vallabhdas Thakker manages the operational activities of the company, bringing expertise in manufacturing and project management. Mr. Chandresh Vallabhdas Thakker, a commerce and law graduate from Mumbai University, oversees the company's legal and financial affairs. Other key executives include Mr. Chinubhai Shantilal Shah, Mr. Mukesh Chandrakant Khagram, Mr. Jay Mukund Thakker, and Ms. Rita Rajesh Kamani, who contribute to the strategic direction and management of GVCL.
Regulated market presence, emerging market penetration, and geographic strategy
GVCL has established a presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company's manufacturing facilities are US FDA approved, indicating compliance with stringent US regulatory standards. GVCL's products are WHO-GMP certified, ISO 9001:2015 certified, and US FDA approved, facilitating market access in these regions. The company's adherence to international quality standards enhances its credibility and acceptance in these regulated markets.
GVCL has expanded its reach into emerging markets, including Africa, Latin America, and Southeast Asia. The company's WHO-GMP certification and adherence to international quality standards enable it to meet the regulatory requirements of these regions. GVCL's focus on quality and compliance positions it favorably to penetrate and establish a strong presence in these emerging markets.
GVCL's export portfolio is concentrated, with its top two products—Zinc and Hydrocortisone—accounting for 100% of its export value. This concentration indicates a focused product strategy, which may expose the company to risks associated with market fluctuations in these specific products. Diversifying its product range could mitigate such risks and enhance GVCL's resilience in the global market.
FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record
GVCL's manufacturing facility is registered with the US FDA, indicating compliance with US regulatory standards. The facility has undergone FDA inspections, with known issues observed during these inspections. The FDA is responsible for inspecting drug manufacturing facilities for violations of good manufacturing practices, such as a lack of documented drug quality testing or contaminated equipment. GVCL's facility has been subject to FDA inspections, and issues have been observed during these inspections.
GVCL's manufacturing facilities are WHO-GMP certified, ensuring adherence to international quality standards. The company also holds ISO 9001:2015 certification, reflecting its commitment to quality management systems. However, there is no specific information available regarding EU GMP certification or EDQM status.
GVCL holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO), the national regulatory authority in India. The company has obtained necessary approvals from state drug controllers and export No Objection Certificates (NOCs), facilitating its export operations. GVCL's compliance with Indian regulatory requirements underscores its commitment to quality and safety in pharmaceutical manufacturing.
GVCL's manufacturing facility has been inspected by the US FDA, with known issues observed during these inspections. The FDA is responsible for inspecting drug manufacturing facilities for violations of good manufacturing practices, such as a lack of documented drug quality testing or contaminated equipment. GVCL's facility has been subject to FDA inspections, and issues have been observed during these inspections.
Market share comparison, key differentiators, and strategic analysis
GVCL operates in a competitive landscape, with several companies offering similar pharmaceutical formulations. While specific market share data is not available, GVCL's focus on quality and compliance with international standards positions it favorably in the market. The company's WHO-GMP certification, ISO 9001:2015 certification, and US FDA approval enhance its credibility and competitiveness.
GVCL's key differentiators include its extensive experience of over 70 years in the pharmaceutical and cosmeceutical sectors, a manufacturing area exceeding 220,000 square feet, and adherence to international quality standards such as WHO-GMP and ISO 9001:2015 certifications. The company's US FDA approval further underscores its commitment to quality and regulatory compliance.
GVCL's current strategic direction focuses on the development and manufacturing of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company's adherence to international quality standards and regulatory approvals positions it well in the global market. Future strategic initiatives may include diversifying its product portfolio and expanding its presence in emerging markets to mitigate concentration risks and enhance growth opportunities.
Track record assessment, certifications to verify, and pre-order checks
GVCL has a track record of over 70 years in the pharmaceutical and cosmeceutical sectors, indicating reliability and experience. The company's manufacturing facilities are WHO-GMP certified, ISO 9001:2015 certified, and US FDA approved, reflecting its commitment to quality and compliance. However, known issues have been observed during FDA inspections, which may impact the company's reliability.
Importers should verify the following certifications to ensure product quality and regulatory compliance:
Each certification can typically be verified through the issuing organization's official website or by contacting the organization directly.
Importers should undertake the following verification steps:
Red flags to watch for include unresolved regulatory issues, expired certifications, and a history of non-compliance. Recommended pre-order checks involve verifying the authenticity of certifications and assessing the company's reputation in the industry.
Gopaldas Visram AND Company Limited exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Zinc ($3.9M), Hydrocortisone ($1.2M). Total export value is $5.2M.
Gopaldas Visram AND Company Limited's total pharmaceutical export value is $5.2M, based on 344 verified shipments recorded in Indian Customs (DGFT) data.
Gopaldas Visram AND Company Limited exports across 2 therapeutic categories. The largest are Vitamins & Supplements (76.3%, 1 products), Corticosteroids (23.7%, 1 products).
Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Verify manufacturer licensing, GMP certification, and export registration with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2 Products Tracked
2 therapeutic categories
Expert-Reviewed
By pharmaceutical trade specialists
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.